Peter Nash
- Rheumatology top 0.02%
- Rheumatoid Arthritis Research and Therapies 193
- Spondyloarthritis Studies and Treatments 143
- Systemic Lupus Erythematosus Research 42
- Hematology top 0.1%
- Autoimmune and Inflammatory Disorders Research 121
- Immunology top 0.2%
- Psoriasis: Treatment and Pathogenesis 110
- Dermatology top 0.2%
- Pathology and Forensic Medicine top 0.5%
- Systemic Sclerosis and Related Diseases 28
- Lymphoma Diagnosis and Treatment 21
-
- Chronic Lymphocytic Leukemia Research 37
- Co-authors
- Dafna D. GladmanDaniel O. CleggPhilip MeaseChristian AntoniPhilip J. MeaseDésirée van der HeijdeLuminita PricopIain B. McInnes
- Cited by
- RheumatologyHematologyImmunology
- Journals
- Annals of the Rheumatic Diseases (90 papers)Rheumatology and Therapy (22 papers)Lara D. Veeken (21 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Peter Nash
338 papers receiving 11.2k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Rheumatology 7.4k
- Hematology 3.8k
- Immunology 5.2k
- Dermatology 1.0k
- Pathology and Forensic Medicine 1.7k
Countries citing papers authored by Peter Nash
This map shows the geographic impact of Peter Nash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Nash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Nash more than expected).
Fields of papers citing papers by Peter Nash
This network shows the impact of papers produced by Peter Nash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Nash. The network helps show where Peter Nash may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Nash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 2 | |
| 6 | 2023 | 2 | |
| 7 | 2023 | 1 | |
| 8 | Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitisbreakdown → | 2023 | 124 |
| 9 | 2022 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2021 | 1 | |
| 12 | 2021 | 33 | |
| 13 | 2021 | 7 | |
| 14 | 2021 | 1 | |
| 15 | 2018 | 27 | |
| 16 | 2017 | 14 | |
| 17 | The role of asymmetric dimethylarginine alone and in combination with N-terminal pro-B-type natriuretic peptide as a screening biomarker for systemic sclerosis-related pulmonary arterial hypertension: a case control study. | 2017 | 16 |
| 18 | Secukinumab, a Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicenter, Double-Blind, Placebo-Controlled Study | 2014 | 12 |
| 19 | 2013 | 1 | |
| 20 | Safety profile of subcutaneous abatacept focusing On clinically relevant events in patients with rheumatoid arthritis and up to 4.5 years of exposure | 2012 | 3 |
About Peter Nash
Peter Nash is a scholar working on Rheumatology, Hematology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 344 papers that have together received 11.5k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (193 papers), Spondyloarthritis Studies and Treatments (143 papers), Autoimmune and Inflammatory Disorders Research (121 papers), Psoriasis: Treatment and Pathogenesis (110 papers), Systemic Lupus Erythematosus Research (42 papers), Chronic Lymphocytic Leukemia Research (37 papers), Systemic Sclerosis and Related Diseases (28 papers) and Lymphoma Diagnosis and Treatment (21 papers). The work is most often cited by research in Rheumatology (7.4k citations), Hematology (3.8k citations), Immunology (5.2k citations), Dermatology (1.0k citations) and Pathology and Forensic Medicine (1.7k citations). Peter Nash has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Dafna D. Gladman, Daniel O. Clegg, Philip Mease, Christian Antoni, Philip J. Mease, Désirée van der Heijde, Luminita Pricop, Iain B. McInnes, Frank Behrens and Paul Emery. Their work appears in journals such as Annals of the Rheumatic Diseases, Rheumatology and Therapy, Lara D. Veeken, RMD Open and The Journal of Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.